TransMedics
ApprovedTransMedics Organ Care System (OCS™): The only FDA-approved technology for lung, heart & liver transplantation indication in the U.S.
Founded
1998
Focus
Medical DevicesOrgan Preservation
About
TransMedics Organ Care System (OCS™): The only FDA-approved technology for lung, heart & liver transplantation indication in the U.S.
Funding History
4Total raised: $141M
IPO$75MUndisclosedMay 15, 2019
Series C$36MUndisclosedJan 15, 2014
Series B$20MUndisclosedJan 15, 2009
Series A$10MUndisclosedJan 15, 2006
Company Info
TypePrivate
Founded1998
LocationAndover, United States
StageApproved
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile